HIV-Specific Immunity Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Curr HIV/AIDS Rep. 2021 Jun;18(3):211-220. doi: 10.1007/s11904-021-00545-2. Epub 2021 Mar 11.
A large amount of data now exists on the virus-specific immune response associated with spontaneous or induced immunologic control of lentiviruses. This review focuses on how the current understanding of HIV-specific immunity might be leveraged into induction of immunologic control and what further research is needed to accomplish this goal.
During chronic infection, the function most robustly associated with immunologic control of HIV-1 is CD8 T cell cytotoxic capacity. This function has proven difficult to restore in HIV-specific CD8 T cells of chronically infected progressors in vitro and in vivo. However, progress has been made in inducing an effective CD8 T cell response prior to lentiviral infection in the macaque model and during acute lentiviral infection in non-human primates. Further study will likely accelerate the ability to induce an effective CD8 T cell response as part of prophylactic or therapeutic strategies.
目前有大量数据表明,与慢病毒的自发性或诱导性免疫控制相关的病毒特异性免疫反应。本综述重点介绍了如何利用目前对 HIV 特异性免疫的理解来诱导免疫控制,以及需要进一步研究哪些内容来实现这一目标。
在慢性感染期间,与 HIV-1 免疫控制最密切相关的功能是 CD8 T 细胞细胞毒性。在体外和体内,已经证明难以恢复慢性感染进展者的 HIV 特异性 CD8 T 细胞中的这种功能。然而,在猕猴模型中,在慢病毒感染之前,以及在非人类灵长类动物的急性慢病毒感染期间,已经在诱导有效的 CD8 T 细胞反应方面取得了进展。进一步的研究可能会加速诱导有效的 CD8 T 细胞反应的能力,作为预防或治疗策略的一部分。